Transfection of cystatin M/E in highly tumorigenic and metastatic human breast cancer cells (MDA-MB-435S cell line) impaired proliferation, migration, matrix invasion and tumor-endothelial cell adhesion, providing the first evidence that cystatin M/E plays a protective role in safeguarding against breast cancer [72]. This evidence concerns the gene CST6 and neoplasm.